The trademark application Neltruze was filed by Shorla Pharma Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on March 21, 2021, and it was registered by office on June 28, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 12, 2023. Change of name and professional address of the trademark registration was recorded on July 3, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical and medicinal drugs, products, preparations and substances
Pharmaceutical and medicinal preparations and substances for use in oncology
Pharmaceutical preparations, products and substances for human use
Pharmaceutical preparations, products and substances for the prevention and treatment of cancer
Compounds for treating cancer
Biological preparations for the treatment of cancer
Pharmaceutical preparations, products and substances for the prevention of tumours
Anti-cancer drugs and preparations.
The mark was filed in class 42 with following description of goods:
Research and development services
Biological research
Scientific research services
Research and development services in the pharmaceutical and biotechnology fields
Research services relating to the development and testing of pharmaceutical preparations and medicines
Pharmaceutical drug development services
Pharmaceutical product evaluation
Testing and inspection of pharmaceutical preparations and medicines
Conducting clinical trials for pharmaceutical products
Product safety and quality testing in the pharmaceutical and biotechnology fields
Provision of information and data relating to research and development in the pharmaceutical and biotechnology fields.